Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 12 of about 12 for Merck & Co., Inc.�
Company Exchange Symbol Last price Quote change Market cap
Ligand Pharmaceuticals Inc. NASDAQ LGND 53.51 -0.39 (-0.72%) 1.08B
Ligand Pharmaceuticals Incorporated (Ligand) is a biotechnology company that operates with a business model focused on developing or acquiring assets.
Merck & Co., Inc. NYSE MRK 59.38 -0.26 (-0.44%) 170.49B
Merck & Co., Inc. (Merck), is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, ...
Enzon Pharmaceuticals Inc NASDAQ ENZN 1.05 -0.01 (-0.94%) 46.57M
Enzon Pharmaceuticals, Inc. (Enzon) is a biotechnology company. The Company's drug development programs utilize two platforms: Customized PEGylation Linker ...
Alkermes Plc NASDAQ ALKS 55.24 +0.98 (1.81%) 7.93B
Alkermes Public Limited Company is an integrated, global biopharmaceutical company. The Company has a portfolio of more than 20 commercial drug products and ...
Xenon Pharmaceuticals Inc NASDAQ XENE 13.17 -0.49 (-3.59%) 188.36M
(Teva) (through its subsidiary, Ivax International GmbH), Genentech, Inc. ( Genentech), and Merck & Co., Inc. (Merck) (through its affiliate, Essex Chemie ...
Nektar Therapeutics NASDAQ NKTR 14.32 +0.56 (4.07%) 1.78B
Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms.
MERCK AND CO INC EPA MRK 47.23 +0.22 (0.47%)
Amphastar Pharmaceuticals Inc NASDAQ AMPH 10.48 +0.27 (2.64%) 461.59M
Amphastar Pharmaceuticals, Inc. is a specialty and generic pharmaceutical company. The Company focuses primarily on developing, manufacturing, marketing and ...
ENZON PHARMACEUT. DL-,01 FRA EZ1 0.828 -0.001 (-0.12%)
ALKERMES PLC DL-,01 FRA 8AK 43.15 +0.95 (2.26%)
NEKTAR THERAPEUTICS FRA ITH 10.81 -0.28 (-2.54%)
MERCK & CO INC CEDEAR (10 REP 1 USD0.50) BCBA MRK 0.000